Cigna Corp. (CI) Tops Q1 EPS by 32c; Guides In-Line; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
CIGNA (CI) PT Raised to $183 at Jefferies Following 1Q Beat
May 8, 2017 7:58 AM EDTJefferies raised its price target on CIGNA (NYSE: CI) to $183.00 (from $178.00) while maintaining a Buy rating. EPS of $2.77 beat estimates by 13% on higher earnings in Healthcare and Group Disability & Life while Global Supp was in-line.
The company's 3% EPS guidance raise pushes the range to... More
CIGNA (CI) PT Raised to $175 at Stifel Following Solid Q1, Outlook
May 5, 2017 11:57 AM EDTStifel raised its price target on CIGNA (NYSE: CI) to $175.00 (from $170.00) while maintaining a Buy rating following solid Q1 results and raised guidance.
Analyst Thomas Carroll noted operating margins for the healthcare and disability businesses were up while the supplemental products were essentially... More
